Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Colon Adenocarcinoma
Age: Between 18 - 80 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required